Patient & HCP Communication Strategies

4 Creative Pharma Communication Strategies to Drive Engagement and Trust

The pharmaceutical and life sciences industry is evolving rapidly, but one challenge persists: how to communicate complex science clearly and creatively. In an era of omnichannel communication where patient-centricity is the cornerstone of trust and engagement, pharma companies must go beyond traditional formats to deliver content that resonates with healthcare professionals (HCPs), patients, caregivers, and…...
Read More

Top Stories

Nelson memo

The Nelson Memo: Igniting a Global Open Data

The landscape of scientific research is undergoing a seismic...
Rare diseases

Rare Diseases – An Evolving Medical

A disease is considered rare when it affects fewer than 1 in...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Medical Device Regulation

Clinical Evidence: How Much Is Enough?

Ensuring the safety and functionality of your medical device is vital. But how much clinical...
Image - Understanding Patient Centricity, Progress Made, and Barriers Encountered Survey Questionnaire and Responses

Survey Report: Understanding Patient Centricity, Progress Made, and Barriers Encountered (Survey Questionnaire and Responses)

Cactus Communications commissioned a survey of pharma/biotech and associated industry professionals to understand the progress...
How Can Preprints Drive Trust In Science?

How Can Preprints Drive Trust in Science?

By tagging preprints with various indicators, badges may represent quality, rigor, and scope. In doing...
reimagining scientific communications

Scientific Communication Strategies for Digital Transformation

Read how digital transformation strategies can help to rethink workflows for future readiness and scale-up...
Publication planning training

Publication Planning Training for Regional Medical Affairs Team

How a global pharma company overcame challenges of integration with regional teams in terms of...
EU MDR Whitepaper

EU MDR: Increasing Expectations for Clinical Evidence

While the global medical devices industry is closely watching how the European Union (EU) Medical...

Learn more ABOUT our company.